What the Options Market Tells Us About Viking Therapeutics
Portfolio Pulse from Benzinga Insights
Viking Therapeutics (NASDAQ:VKTX) has seen significant bullish options activity, with 57% of investors leaning bullish. The options market suggests a price target range of $30 to $100. Despite a recent 5.63% price drop, analysts have set an average target price of $92.5. The stock is currently neutral on RSI, with earnings expected in 36 days.
September 17, 2024 | 5:46 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Viking Therapeutics has experienced significant bullish options activity, with 57% of investors showing a positive sentiment. The options market indicates a potential price range of $30 to $100. Despite a recent price drop of 5.63%, analysts have set an average target price of $92.5, with upcoming earnings in 36 days.
The significant bullish options activity suggests investor confidence in Viking Therapeutics, despite a recent price drop. The options market's price target range and analyst ratings indicate potential for upward movement. The upcoming earnings release could further impact the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100